<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03627533</url>
  </required_header>
  <id_info>
    <org_study_id>Medical Acupuncture</org_study_id>
    <nct_id>NCT03627533</nct_id>
  </id_info>
  <brief_title>The Differences of Oocyte Maturation, Granulosa Cell Apoptosis Index Between Electroacupuncture And Sham Groups IVF</brief_title>
  <official_title>The Differences of Oocyte Maturation, Granulosa Cell Apoptosis Index Between Electroacupuncture And Sham Groups IVF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr Cipto Mangunkusumo General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional studies compared electroacupuncture group versus sham electroacupuncture group
      to granulosa cell apoptosis index, oocyte maturation, GDF9 and BMP15 levels, and
      fertilization rate in in vitro fertilization program
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was conducted at the Dr.Cipto Mangunkusumo National General Hospital, Indonesia in
      September - November 2018.The inclusion criteria are patients who underwent controlled
      ovarian stimulation with antagonist protocol, age 30-39 years, BMI &lt;29kg / m2. Exclusion
      criteria were not having a skin infection at acupuncture point and not using a pacemaker.
      Then patients were randomly divided into two groups: electroacupuncture and sham
      electroacupuncture. Electroacupuncture therapy was done 6 times at: 2 times before and 4
      times during controlled ovarian stimulation.Apoptotic index of granulosa cells were examined
      by quantitative real time PCR techniques for BAX/BCL-2 expression.Oocyte maturation and
      fertilization rate output parameters are examined by competent embryologists after ovum pick
      up while GDF9 and BMP15 levels were examined by quantitative real time PCR techniques for
      GDF9 and BMP15 mRNA expression
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 17, 2018</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>electroacupuncture versus sham electroacupuncture</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Index apoptotic (Ratio Bax/Bcl-2) of granulosa cells, GDF9 and BMP15</measure>
    <time_frame>&quot;up to 1 months&quot;</time_frame>
    <description>Bax/Bcl-2 is proapoptotic protein compare to antiapoptotic protein. GDF9 and BMP15 protein expression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>oocyte maturation index</measure>
    <time_frame>&quot;up to 1 months&quot;</time_frame>
    <description>fertilization rate is number of fertilized oocytes compared with all total number oocyte which taken when ovum pick-up. oocyte maturation index is the number of mature oocyte (metaphase II oocyte) compare with all total number oocyte which taken when ovum pick-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>&quot;up to 1 months&quot;</time_frame>
    <description>fertilization rate is number of fertilized oocytes compared with all total number oocyte which taken when ovum pick-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Acupuncture</condition>
  <condition>in Vitro Fertilization</condition>
  <condition>BCL2 Gene mRNA Overexpression</condition>
  <condition>Oocyte Maturation</condition>
  <arm_group>
    <arm_group_label>Electroacupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electroacupuncture therapy is done at the point of CV3 Zhongji, CV4 Guanyuan, and EXCA-1 Zigong with continuous wave, 2 Hz frequency for 30 minutes. Acupuncture manuals on MA-IC3 endocrine (ear points), GV20 Baihui, ST36 Zusanli, SP6 Sanyinjiao, BL57 Chengsan and KI3 Taixi for 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham electroacupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham electroacupuncture are done at same electroacupuncture point location but puncture are not done, also electro stimulator are turned off.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electroacupuncture</intervention_name>
    <description>Electroacupuncture therapy is done at the point of CV3 Zhongji, CV4 Guanyuan, and EXCA-1 Zigong with continuous wave, 2 Hz frequency for 30 minutes. Acupuncture manuals on endocrine ear points, GV20 Baihui, ST36 Zusanli, SP6 Sanyinjiao, BL57 Chengsan and KI3 Taixi for 30 minutes.</description>
    <arm_group_label>Electroacupuncture</arm_group_label>
    <arm_group_label>Sham electroacupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women underwent controlled ovarian stimulation with antagonist protocol

          -  BMI &lt; 29 kg/m2

          -  willing and sign the inform consent

          -  follow the research until completed

        Exclusion Criteria:

          -  having skin infection at acupoint location

          -  use a pacemaker
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Simadibrata, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical Acupuncture of Indonesian University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indonesian University</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>nadia oktari</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

